Alkermes plc. Earnings Per Share (Diluted)
Alkermes plc. (ALKS) reported Earnings Per Share (Diluted) of $0.00 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-28.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareDiluted · last filed 2026-07-28
- Alkermes plc. earnings per share, diluted for the quarter ending 2026-06-30 was $0.00, a 100.00% decline year-over-year.
- Alkermes plc. earnings per share, diluted for the quarter ending 2026-03-31 was -$0.40, a 407.69% decline year-over-year.
- Alkermes plc. earnings per share, diluted for the quarter ending 2025-12-31 was $0.29, a 66.99% decline year-over-year.
- Alkermes plc. earnings per share, diluted for the quarter ending 2025-09-30 was $0.49, a 10.91% decline year-over-year.
- Alkermes plc. earnings per share, diluted for fiscal 2025 was $1.43, a 34.10% decline from fiscal 2024.
- Alkermes plc. earnings per share, diluted for fiscal 2024 was $2.17, a 3.33% increase from fiscal 2023.
- Alkermes plc. earnings per share, diluted for fiscal 2023 was $2.10.
- Alkermes plc. earnings per share, diluted for fiscal 2022 was -$0.97.
| Period end | Earnings Per Share, Diluted 3 month | Earnings Per Share, Diluted 6 month | Earnings Per Share, Diluted 9 month | Earnings Per Share, Diluted 12 month | Earnings Per Share, Diluted 12 month as first filed |
|---|---|---|---|---|---|
| 2026-06-30 | $0.00 10-Q · filed 2026-07-28 | -$0.40 10-Q · filed 2026-07-28 | -$0.10 derived: net income ÷ weighted average shares · filed 2026-07-28 | $0.39 derived: net income ÷ weighted average shares · filed 2026-07-28 | |
| 2026-03-31 | -$0.40 10-Q · filed 2026-05-05 | -$0.10 derived: net income ÷ weighted average shares · filed 2026-07-28 | $0.39 derived: net income ÷ weighted average shares · filed 2026-07-28 | $0.91 derived: net income ÷ weighted average shares · filed 2026-07-28 | |
| 2025-12-31 | $0.29 derived: net income ÷ weighted average shares · filed 2026-04-06 | $0.78 derived: net income ÷ weighted average shares · filed 2026-04-06 | $1.30 derived: net income ÷ weighted average shares · filed 2026-07-28 | $1.43 10-K · filed 2026-02-25 | |
| 2025-09-30 | $0.49 10-Q · filed 2025-10-28 | $1.01 derived: net income ÷ weighted average shares · filed 2026-07-28 | $1.14 10-Q · filed 2025-10-28 | $2.02 derived: net income ÷ weighted average shares · filed 2026-07-28 | |
| 2025-06-30 | $0.52 10-Q · filed 2026-07-28 | $0.65 10-Q · filed 2026-07-28 | $1.53 derived: net income ÷ weighted average shares · filed 2026-07-28 | $2.08 derived: net income ÷ weighted average shares · filed 2026-07-28 | |
| 2025-03-31 | $0.13 10-Q · filed 2026-05-05 | $1.01 derived: net income ÷ weighted average shares · filed 2026-07-28 | $1.56 derived: net income ÷ weighted average shares · filed 2026-07-28 | $2.10 derived: net income ÷ weighted average shares · filed 2026-07-28 | |
| 2024-12-31 | $0.88 derived: net income ÷ weighted average shares · filed 2026-04-06 | $1.43 derived: net income ÷ weighted average shares · filed 2026-04-06 | $1.97 derived: net income ÷ weighted average shares · filed 2026-04-06 | $2.17 10-K · filed 2026-02-25 | |
| 2024-09-30 | $0.55 10-Q · filed 2025-10-28 | $1.09 derived: net income ÷ weighted average shares · filed 2025-10-28 | $1.30 10-Q · filed 2025-10-28 | $1.97 derived: net income ÷ weighted average shares · filed 2026-04-06 | |
| 2024-06-30 | $0.53 10-Q · filed 2025-07-29 | $0.75 10-Q · filed 2025-07-29 | $1.42 derived: net income ÷ weighted average shares · filed 2026-04-06 | $1.69 derived: net income ÷ weighted average shares · filed 2026-04-06 | |
| 2024-03-31 | $0.21 10-Q · filed 2025-05-01 | $0.88 derived: net income ÷ weighted average shares · filed 2026-04-06 | $1.16 derived: net income ÷ weighted average shares · filed 2026-04-06 | $2.55 derived: net income ÷ weighted average shares · filed 2026-04-06 | |
| 2023-12-31 | $0.68 derived: net income ÷ weighted average shares · filed 2026-04-06 | $0.95 derived: net income ÷ weighted average shares · filed 2026-04-06 | $2.34 derived: net income ÷ weighted average shares · filed 2026-04-06 | $2.10 10-K · filed 2026-02-25 | |
| 2023-09-30 | $0.28 10-Q · filed 2024-10-24 | $1.66 derived: net income ÷ weighted average shares · filed 2024-10-24 | $1.42 10-Q · filed 2024-10-24 | $1.28 derived: net income ÷ weighted average shares · filed 2026-04-06 | |
| 2023-06-30 | $1.38 10-Q · filed 2024-07-24 | $1.14 10-Q · filed 2024-07-24 | $1.00 derived: net income ÷ weighted average shares · filed 2026-04-06 | $0.62 derived: net income ÷ weighted average shares · filed 2026-04-06 | |
| 2023-03-31 | -$0.25 10-Q · filed 2024-05-01 | -$0.43 derived: net income ÷ weighted average shares · filed 2026-04-06 | -$0.81 derived: net income ÷ weighted average shares · filed 2026-04-06 | -$1.00 derived: net income ÷ weighted average shares · filed 2026-04-06 | |
| 2022-12-31 | -$0.17 derived: net income ÷ weighted average shares · filed 2026-04-06 | -$0.56 derived: net income ÷ weighted average shares · filed 2026-04-06 | -$0.75 derived: net income ÷ weighted average shares · filed 2026-04-06 | -$0.97 10-K · filed 2025-02-12 | |
| 2022-09-30 | -$0.39 10-Q · filed 2023-10-25 | -$0.57 derived: net income ÷ weighted average shares · filed 2023-10-25 | -$0.79 10-Q · filed 2023-10-25 | -$0.77 derived: net income ÷ weighted average shares · filed 2026-04-06 | |
| 2022-06-30 | -$0.18 10-Q · filed 2023-07-26 | -$0.40 10-Q · filed 2023-07-26 | -$0.39 derived: net income ÷ weighted average shares · filed 2026-04-06 | -$0.57 derived: net income ÷ weighted average shares · filed 2026-04-06 | |
| 2022-03-31 | -$0.22 10-Q · filed 2023-04-26 | -$0.21 derived: net income ÷ weighted average shares · filed 2026-04-06 | -$0.38 derived: net income ÷ weighted average shares · filed 2026-04-06 | -$0.37 derived: net income ÷ weighted average shares · filed 2026-04-06 | |
| 2021-12-31 | $0.00 derived: net income ÷ weighted average shares · filed 2026-04-06 | -$0.17 derived: net income ÷ weighted average shares · filed 2026-04-06 | -$0.15 derived: net income ÷ weighted average shares · filed 2026-04-06 | -$0.29 10-K · filed 2024-02-21 | -$0.30 10-K · filed 2023-02-16 |
| 2021-09-30 | -$0.18 10-Q · filed 2022-11-02 | -$0.16 derived: net income ÷ weighted average shares · filed 2022-11-02 | -$0.31 10-Q · filed 2022-11-02 | ||
| 2021-06-30 | $0.01 10-Q · filed 2022-07-27 | -$0.13 10-Q · filed 2022-07-27 | |||
| 2020-12-31 | -$0.70 10-K · filed 2023-02-16 | ||||
| 2020-06-30 | -$0.19 derived: net income ÷ weighted average shares · filed 2021-10-27 | -$0.43 derived: net income ÷ weighted average shares · filed 2021-07-28 | |||
| 2015-12-31 | -$1.52 10-K · filed 2016-02-25 | ||||
| 2015-06-30 | -$0.31 10-Q · filed 2015-07-30 | -$0.52 10-Q · filed 2015-07-30 | |||
| 2014-12-31 | -$0.21 10-K · filed 2016-02-25 | ||||
| 2014-09-30 | -$0.27 10-Q · filed 2014-10-29 | -$0.42 10-Q · filed 2014-10-29 | |||
| 2014-06-30 | $0.02 10-Q · filed 2015-07-30 | -$0.14 10-Q · filed 2015-07-30 | |||
| 2014-03-31 | -$0.17 10-Q · filed 2014-04-30 | ||||
| 2013-12-31 | $0.12 10-K · filed 2016-02-25 | $0.14 10-K · filed 2016-02-25 | |||
| 2013-09-30 | -$0.06 10-Q · filed 2014-10-29 | $0.00 10-Q · filed 2013-10-31 | $0.02 10-Q · filed 2014-10-29 | ||
| 2013-06-30 | $0.05 10-Q · filed 2014-07-31 | $0.07 10-Q · filed 2014-07-31 | |||
| 2013-03-31 | $0.02 10-Q · filed 2014-04-30 | $0.18 10-K · filed 2015-02-24 | |||
| 2012-12-31 | $0.12 10-Q · filed 2013-01-31 | $0.16 10-K · filed 2015-02-24 | |||
| 2012-09-30 | -$0.13 10-Q · filed 2013-10-31 | $0.04 10-Q · filed 2013-10-31 | |||
| 2012-06-30 | $0.17 10-Q · filed 2013-07-25 | ||||
| 2012-03-31 | -$0.49 derived: net income ÷ weighted average shares · filed 2014-02-27 | -$0.60 derived: net income ÷ weighted average shares · filed 2014-02-27 | -$0.83 derived: net income ÷ weighted average shares · filed 2014-02-27 | -$0.99 10-KT · filed 2014-02-27 | |
| 2011-12-31 | -$0.11 10-Q · filed 2013-01-31 | -$0.32 derived: net income ÷ weighted average shares · filed 2013-01-31 | -$0.46 10-Q · filed 2013-01-31 | ||
| 2011-09-30 | -$0.22 10-Q · filed 2012-11-01 | -$0.36 10-Q · filed 2012-11-01 | |||
| 2011-03-31 | -$0.48 10-K · filed 2013-05-23 | ||||
| 2010-03-31 | -$0.42 10-K · filed 2012-05-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |